Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20490839 | 0.91 | ALDH1A1 (0.44) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL12775672 | 0.82 | CYP3A4 (0.59) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL127434 | 0.81 | CYP3A4 (0.47) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL358896 | 0.80 | CYP3A4 (0.53) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL7764968 | 0.79 | CYP3A4 (0.45) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL30504565 | 0.78 | NR1I2 (0.47) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL83519 | 0.78 | CYP3A4 (0.50) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL19644362 | 0.77 | SMN1; SMN2 (0.50) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL788296 | 0.77 | SMN1; SMN2 (0.50) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL17728691 | 0.76 | CYP3A4 (0.45) | CYP3A4SMN1; SMN2ALDH1A1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2519570-A1 | HIGH INTERNAL PHASE EMULSION COMPRISING TWO OR MORE LAYERS AND HAVING A PHOTOINITIATOR | The Procter & Gamble Company (US) | 2012-11-07 | — | — | EP | claimed |
| WO-2011081802-A1 | HIGH INTERNAL PHASE EMULSION COMPRISING TWO OR MORE LAYERS AND HAVING A PHOTOINITIATOR | THE PROCTER & GAMBLE COMPANY (US) | 2011-07-07 | — | — | WO | claimed |
| EP-1660019-B1 | POLYMERIZABLE DENTAL COMPOSITION HAVING A HIGH CONTENT OF LOADING MATERIAL | BLUESTAR SILICONES FRANCE (FR) | 2010-07-14 | — | — | EP | claimed |
| US-20060025521-A1 | Polymerizing hydrogels including modifying compounds to comprise low amount of residual monomers and by-products and to optimize material properties | BASF AKTIENGESELLSCHAFT A GERMAN CORPORATION (DE) | 2006-02-02 | — | — | US | claimed |
| US-5843576-A | Floor covering with coating composition | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1998-12-01 | — | — | US | claimed |
| US-20260137565-A1 | PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS | THE PROCTER & GAMBLE CO (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260138767-A1 | PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS | THE PROCTER & GAMBLE CO (US) | 2026-05-21 | — | — | US | disclosed |
| EP-3618789-B1 | ABSORBENT ARTICLE HAVING MULTIPLE ZONES | PROCTER & GAMBLE (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20260051498-A1 | Electrode for Lithium Secondary Battery and Method for Manufacturing the Same | LG CHEM, LTD. (KR) | 2026-02-19 | — | — | US | disclosed |
| EP-4688920-A1 | METHOD FOR PREPARING ORGANOPOLYSILOXANES WITH (METH)ACRYLATE FUNCTIONS | Elkem Silicones France SAS (FR) | 2026-02-11 | — | — | EP | disclosed |
| EP-3558203-B1 | ABSORBENT STRUCTURE | PROCTER & GAMBLE (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12491123-B2 | Absorbent structure | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-09 | — | — | US | disclosed |
| EP-1245241-A1 | Polymerized hydrogel adhesives comprising low amounts of residual monomers | The Procter & Gamble Company (US) | 2002-10-02 | — | — | EP | disclosed |
| EP-1245240-A1 | Skin-compatible hydrogel adhesives and personal care products containing them | THE PROCTER & GAMBLE COMPANY (US) | 2002-10-02 | — | — | EP | disclosed |
| EP-1228813-A2 | Surface covering having gloss in register and method of making | Armstrong World Industries, Inc. (US) | 2002-08-07 | — | — | EP | disclosed |
| WO-2002018116-A1 | METHOD OF POLYMERIZING RESIN COMPOSITION CONTAINING A VOLATILE MATERIAL, PRODUCT FORMED THEREBY AND APPARATUS FOR PERFORMING THE METHOD | FUSION UV SYSTEMS, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| EP-1092740-A1 | Ultraviolet curable resin compositions having enhanced shadow cure properties | RHEOX, INC. (US) | 2001-04-18 | — | — | EP | disclosed |
| US-5843576-A | Floor covering with coating composition | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1998-12-01 | — | — | US | disclosed |
| US-5719227-A | WEAR RESISTANT ACRYLATED POLYURETHANE | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1998-02-17 | — | — | US | disclosed |
| EP-0783008-A2 | Coating composition and floor covering including the composition | Armstrong World Industries, Inc. (US) | 1997-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137565-A1 | PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS | SHBG, SMCHD1, CUTA | CYP3A4 2588/4885SMN1; SMN2 1830/4885ALDH1A1 393/4885 |
| US-20260138767-A1 | PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS | CUTA, SMCHD1, RFT1 | CYP3A4 2262/4885SMN1; SMN2 2136/4885ALDH1A1 1802/4885 |
| US-20260051498-A1 | Electrode for Lithium Secondary Battery and Method for Manufacturing the Same | ILK, EPCAM, L1CAM | CYP3A4 2821/4885SMN1; SMN2 2341/4885ALDH1A1 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.